Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-ISrđan Verstovšek, H. Kantarjian, John F. DiPersio et al.|Haematologica|2013Cited by 162
Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromesOlga Pozdnyakova, Sa A. Wang, Patricia M. Miron et al.|Cancer|2008Cited by 113
In vivo determinations of labelling index of metastatic colorectal carcinoma and normal colonic mucosa using intravenous infusions of bromodeoxyuridineSeema A. Khan, Arnold Mittleman, Azra Raza et al.|Journal of Surgical Oncology|1988Cited by 22
A Phase I Trial of a Pharmacodynamically-Conceived Decitabine and Thioguanine Combination in Patients with Advanced Myeloid MalignanciesTodd Rosenblat, Mark G. Frattini, Mark Heaney et al.|Blood|2014Cited by 1
A phase I trial of a pharmacodynamically-conceived decitabine/thioguanine combination in patients with advanced myeloid malignancies.Todd Rosenblat, Mark G. Frattini, Joseph G. Jurcic et al.|Journal of Clinical Oncology|2015Cited by 0